Step by Step

INTRODUCTION

ABIM and DOB Data Collection

6/1/2021 - Medical Grand Rounds: Health Policy Debate

QUIZ

EVALUATION

CERTIFICATE

INTRODUCTION

Credit Hours: CME 1.00

Target Audience:

Faculty, residents, fellows, and community physicians in General Internal Medicine and subspecialties.

Traditional Risk-Based Approach to the Prevention and Treatment of ASCVD: An Evolving Model That Works
Presented by: Aryan Aiyer, MD

A Polypill Approach to Primary CVD Prevention
Presented by: Philip Joseph, MD

Educational Objectives:

Upon completion of this activity, participants should be able to:

  • Improve the practioner’s knowledge of how secondary ASCVD prevention guidelines have evolved over the last 30 years in the face of new clinical trial data
  • Enhance patient outcomes by implementing advanced lipid lowering therapies and how best to incorporate in current and future practice
  • Improve population metrics regarding adherence to ASCVD prevention measures
  • Implement precision guided approach to application of therapeutic algorithms
  • Recognize current gaps and barriers to hypertension management
  • Summarize the evidence supporting a polypill strategy in primary CVD prevention
  • Examine how a polypill strategy could be implemented in primary CVD prevention

Suggested Additional Reading & Joint Accreditation Statement:

Suggested additional reading:

  • 2018 ACC/AHA Guideline on the Management of Blood Cholesterol
  • 2019 ACC/AHA ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
  • Fourier Trial: Sabatine MS, et al. NEJM 2017;376:1713-22
  • Odyssey Trial: Schwartz GG, et al. NEJM 2018;379;2097-2107
  • Whitehead et al. Nat Rev Drug Discov. 2009;8:129-38
  • Mitchell JD, et al. JACC 2018;72:3233-3242
  • Nasir, K, et al. JACC 2015;66(15):1658-68
  • Ridker PM. NEJM 2018;379:1572-1574
  • Lancet. 2019 Aug 24;394(10199):672-683.
  • N Engl J Med. 2021 Jan 21;384(3):216-228
  • JAMA. 2013 Sep 4;310(9):959-68. doi: 10.1001/jama.2013.184182.


    • Joint Accreditation Statement
    In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    The University of Pittsburgh School of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit[s]™. Physicians should only claim credit commensurate with the extent of their participation in the activity. This educational activity is approved for 1.0 contact hours.

    Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

    Authors:
    Aryan Aiyer, MD — Assistant Professor of Medicine, Division of Cardiology, University of Pittsburgh School of Medicine
    No relationships with industry relevant to the content of this educational activity have been disclosed.
    Philip Joseph, MD — Associate Professor of Medicine, Division of Cardiology, University of Pittsburgh School of Medicine
    Dr. Joseph receives grant/research support from Cadila Pharmaceuticals.
    No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

    This activity is approved for AMA PRA Category 1 Credit™

    The University of Pittsburgh is an affirmative action, equal opportunity institution.